Please Wait.....
Report
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
Market Research Report I 2025-03-05 I 81 Pages I BCC Research
Description
Report Scope
This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.
This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.
Report Includes
- Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
- Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
- An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
- Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
- Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
- Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments
Executive Summary
Summary:
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
The MENA region presents a unique and attractive opportunity for clinical trial market studies. The region has a diverse and rapidly growing population with varying genetic backgrounds, making it ideal for studying disease heterogeneity and treatment efficacy across different demographics. This diversity can significantly contribute to the global understanding of diseases and enhance the generalizability of clinical trial outcomes. Moreover, the MENA region is witnessing a rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders and neurological conditions, which necessitates increased research efforts to address the growing healthcare burden.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Reasons for Doing this Study
Market Summary
Chapter 2 MENA Clinical Trial Industry Outlook
Global Clinical Trial Market Overview
MENA Share
Evolving MENA Clinical Trial Industry
Infrastructure and Resources: Bridging Gaps in Emerging Markets
Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
Cost-Effectiveness
Regulatory Environment: Harmonization and Local Adaptations
Government Support and Investments
Impact of Regional Policies: Incentivizing Clinical Research
Collaborations Expand Regional Networks
Emerging Trends: Focus on Precision Medicine and Rare Diseases
Growing Demand in Oncology and Rare Diseases
Technological Advances: Digitalizing Clinical Operations
Understanding the MENA Clinical Trial Landscape
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Regulatory Frameworks Driving Trial Feasibility
Growing Patient Population Enhancing Recruitment and Diversity
Technological Advances Streamlining Operations
Collaborations
Personalized Medicine Shaping Trial Design
Market Challenges
Complex Regulatory Landscape
Limited Patient Recruitment and Retention
Insufficient Infrastructure and Site Capacity
Limited Adoption of Digital Technologies
Competition for Key Therapeutic Areas
Market Opportunities
Regulatory Reforms Enabling Faster Approvals
Emerging Focus on Oncology and Rare Diseases
Public-Private Partnerships Boosting Research Capacity
Focus on Precision Medicine and Genomics
Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Sponsor Type
Market Analysis, by Phase
Market Analysis, by Service Type
Market Analysis, by Study Type
Market Analysis, by Therapeutic Area
Chapter 5 Emerging Markets
Egypt
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Kingdom of Saudi Arabia (KSA)
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Lebanon
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
United Arab Emirates
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Iran
Overview
Clinical Trial Landscape Analysis
Observations
BCC Recommendations
Chapter 6 Russia-Ukraine War Impact Analysis
Overview
Supply Chain Disruptions
Regulatory Challenges
Patient Recruitment and Retention
Geopolitical Risks
Chapter 7 Competitive Landscape
Overview
Competitive Landscape
International CROs and Pharmaceutical Companies
Local CROs and Institutions
Academic and Research Institutions
Mapping of Clinical Trial Product Services
Recent Developments in Clinical Trials in the MENA Region
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
Research Steps
Sources
Abbreviations
List of Tables
Summary Table : MENA Market for Clinical Trials, by Country, Through 2029
Table 1 : MENA Clinical Trial Analysis, by Study Status, Through 2024
Table 2 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 3 : Comparison of MENA Clinical Trial Regulations, Through 2024
Table 4 : MENA Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 5 : Regulatory Bodies for Conducting Clinical Trials in the MENA Region
Table 6 : Recent Technological Advances in the MENA Clinical Trial Market, 2023 and 2024
Table 7 : Recent Collaborations in the MENA Clinical Trial Market, 2024
Table 8 : Recent Developments in Clinical Trial Infrastructure in MENA, 2023 and 2024
Table 9 : Leading Causes of Death in MENA, by Country, 2021
Table 10 : Recent Developments in the MENA Region, 2023 and 2024
Table 11 : Recent Collaborations in the MENA Region, 2024
Table 12 : Leading MENA Countries for Clinical Trials, by Sponsor Type, Through 2024
Table 13 : MENA Market for Clinical Trials, by Sponsor Type, Through 2029
Table 14 : Leading MENA Countries for Clinical Trials, by Phase, Through 2024
Table 15 : MENA Market for Clinical Trials, by Phase, Through 2029
Table 16 : MENA Market for Clinical Trials, by Service Type, Through 2029
Table 17 : Leading MENA Countries for Clinical Trials, by Study Type, Through 2024
Table 18 : MENA Market for Clinical Trials, by Study Type, Through 2029
Table 19 : MENA Market for Clinical Trials, by Therapeutic Area, Through 2029
Table 20 : Egyptian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 21 : Companies and Research Institutes for Clinical Trials in Egypt
Table 22 : Egyptian Market for Clinical Trials, by Value, Through 2029
Table 23 : Saudi Arabian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 24 : Companies and Research Institutes for Clinical Trials in the KSA
Table 25 : Saudi Arabian Market for Clinical Trials, by Value, Through 2029
Table 26 : Lebanese Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 27 : Companies and Research Institutes for Clinical Trials in Lebanon
Table 28 : Lebanese Market for Clinical Trials, by Value, Through 2029
Table 29 : UAE Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 30 : Companies and Research Institutes for Clinical Trials in UAE
Table 31 : UAE Market for Clinical Trials, by Value, Through 2029
Table 32 : Iranian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
Table 33 : Companies and Research Institutes for Clinical Trials in Iran
Table 34 : Iranian Market for Clinical Trials, by Value, Through 2029
Table 35 : MENA Clinical Trials Product/Services Mapping Analysis
Table 36 : Recent Developments in the MENA Clinical Trial Market, 2020-2024
Table 37 : Information Sources in this Report
Table 38 : Abbreviations Used in this Report
List of Figures
Summary Figure : MENA Market for Clinical Trials, by Country, 2023-2029
Figure 1 : Global Market for Clinical Trials, by Value, 2023-2029
Figure 2 : Share of the Global Clinical Trials Market Value, by Region, 2023
Figure 3 : Key Considerations for MENA Clinical Trials
Figure 4 : Market Dynamics of Clinical Trial Infrastructure in the MENA Region
Figure 5 : Share of Deaths, by Broad Cause, by Country, 2021
Figure 6 : Share of MENA Market for Clinical Trials, by Sponsor Type, 2023
Figure 7 : Share of MENA Market for Clinical Trials, by Phase, 2023
Figure 8 : Share of MENA Market for Clinical Trials, by Service Type, 2023
Figure 9 : Share of MENA Market for Clinical Trials, by Study Type, 2023
Figure 10 : Share of MENA Market for Clinical Trials, by Therapeutic Area, 2023
Figure 11 : Egyptian Market for Clinical Trials, by Value, 2023-2029
Figure 12 : BCC Recommendations for the Egyptian Market for Clinical Trials
Figure 13 : Saudi Arabian Market for Clinical Trials, by Value, 2023-2029
Figure 14 : BCC Recommendations for Saudi Arabian Clinical Trials
Figure 15 : Lebanese Market for Clinical Trials, by Value, 2023-2029
Figure 16 : BCC Recommendations for Lebanese Clinical Trials
Figure 17 : UAE Market for Clinical Trials, by Value, 2023-2029
Figure 18 : BCC Recommendations for the UAE Clinical Trials
Figure 19 : Iranian Market for Clinical Trials, by Value, 2023-2029
Figure 20 : BCC Recommendations for the Iranian Clinical Trials
Figure 21 : Share of MENA Market for Clinical Trials, by Stakeholder, 2024
Figure 22 : Recommendations for Companies Looking to Enter the MENA Clinical Trial Market
Figure 23 : Methodology Used in the MENA Clinical Trial Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security